Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Association of SENPs single-nucleotide polymorphism and breast cancer in Chinese population.

Cai J, Wei X, Zhang G, Sui Y, Zhuang J, Liu Z, Sun H.

Medicine (Baltimore). 2019 Feb;98(6):e14168. doi: 10.1097/MD.0000000000014168.

2.

Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.

Mirecka A, Morawiec Z, Wozniak K.

Pathol Oncol Res. 2016 Oct;22(4):817-23. doi: 10.1007/s12253-016-0064-7. Epub 2016 May 13.

3.
4.

Association between single nucleotide polymorphisms in the TSPYL6 gene and breast cancer susceptibility in the Han Chinese population.

Liu M, Li B, Guo W, Zhang X, Chen Z, Li J, Yan M, Chen C, Jin T.

Oncotarget. 2016 Aug 23;7(34):54771-54781. doi: 10.18632/oncotarget.10754.

5.

Effect of HOTAIR rs920778 polymorphism on breast cancer susceptibility and clinicopathologic features in a Turkish population.

Bayram S, Sümbül AT, Batmacı CY, Genç A.

Tumour Biol. 2015 May;36(5):3863-70. doi: 10.1007/s13277-014-3028-0. Epub 2015 Jan 14.

PMID:
25586347
6.

IL-1RN gene polymorphisms are associated with breast cancer risk in a Chinese Han population.

Jin T, Cao W, Zuo X, Li M, Yang Y, Liang T, Yang H, Zhao X, Yang D.

J Gene Med. 2017 Dec;19(12). doi: 10.1002/jgm.2996. Epub 2017 Nov 9.

PMID:
29047186
7.

Genetic Variation in Metastasis-Associated in Colon Cancer-1 and the Risk of Breast Cancer Among the Chinese Han Population: A STROBE-Compliant Observational Study.

Dai ZJ, Liu XH, Kang HF, Wang XJ, Jin TB, Zhang SQ, Feng T, Ma XB, Wang M, Feng YJ, Liu K, Xu P, Guan HT.

Medicine (Baltimore). 2016 Feb;95(6):e2801. doi: 10.1097/MD.0000000000002801.

8.

Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.

Hardi H, Melki R, Boughaleb Z, El Harroudi T, Aissaoui S, Boukhatem N.

BMC Cancer. 2018 Mar 15;18(1):292. doi: 10.1186/s12885-018-4214-z.

9.

Polymorphisms in TIM-3 and breast cancer susceptibility in Chinese women: A case-control study.

Wang Z, Liu X, Wang X, Chong T, Lin S, Wang M, Ma X, Liu K, Xu P, Feng Y, Dai Z.

Oncotarget. 2016 Jul 12;7(28):43703-43712. doi: 10.18632/oncotarget.9665.

10.

Genetic association of deleted in colorectal carcinoma variants with breast cancer risk: A case-control study.

Liu X, Wang X, Fu SW, Wang M, Kang H, Guan H, Zhang S, Ma X, Lin S, Liu K, Feng Y, Dai C, Dai Z.

Oncotarget. 2016 May 31;7(22):32765-73. doi: 10.18632/oncotarget.9024.

11.

Genetic variants in the acylphosphatase 2 gene and the risk of breast cancer in a Han Chinese population.

Zhang F, Zhang Y, Deng Z, Xu P, Zhang X, Jin T, Liu Q.

Oncotarget. 2016 Dec 27;7(52):86704-86712. doi: 10.18632/oncotarget.13495.

12.

A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.

Li T, Zhao J, Yang J, Ma X, Dai Q, Huang H, Wang L, Liu P.

PLoS One. 2016 Apr 12;11(4):e0153314. doi: 10.1371/journal.pone.0153314. eCollection 2016. Erratum in: PLoS One. 2018 Jan 17;13(1):e0191579.

13.

Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the Chinese population.

Zhao Y, Diao Y, Wang X, Lin S, Wang M, Kang H, Yang P, Dai C, Liu X, Liu K, Li S, Zhu Y, Dai Z.

Oncotarget. 2016 Sep 6;7(36):58174-58180. doi: 10.18632/oncotarget.11272.

14.

Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women.

Han JY, Wang H, Xie YT, Li Y, Zheng LY, Ruan Y, Song AP, Tian XX, Fang WG.

PLoS One. 2012;7(11):e49296. doi: 10.1371/journal.pone.0049296. Epub 2012 Nov 21.

15.

Association analysis of interleukin-18 gene promoter region polymorphisms and susceptibility to sporadic breast cancer in Chinese Han women.

Qiao X, Xu D, Sun D, Sun S, Huang Z, Cui W.

J Clin Lab Anal. 2018 Nov;32(9):e22591. doi: 10.1002/jcla.22591. Epub 2018 Jun 21.

PMID:
29926984
16.

Polymorphisms in lncRNA HOTAIR and susceptibility to breast cancer in a Chinese population.

Yan R, Cao J, Song C, Chen Y, Wu Z, Wang K, Dai L.

Cancer Epidemiol. 2015 Dec;39(6):978-85. doi: 10.1016/j.canep.2015.10.025. Epub 2015 Nov 9.

PMID:
26547792
17.

Genetic variants of ESR1 and SGSM3 are associated with the susceptibility of breast cancer in the Chinese population.

Tan T, Zhang K, Chen W.

Breast Cancer. 2017 May;24(3):369-374. doi: 10.1007/s12282-016-0712-5. Epub 2016 Jul 18. Erratum in: Breast Cancer. 2017 May;24(3):375. Sun WC [corrected to Chen W].

PMID:
27432265
18.

Single nucleotide polymorphism 6q25.1 rs2046210 and increased risk of breast cancer.

Pei J, Li F, Wang B.

Tumour Biol. 2013 Dec;34(6):4073-9. doi: 10.1007/s13277-013-0997-3. Epub 2013 Jul 26.

PMID:
23888322
19.

Estrogen receptor-alpha polymorphism in a Taiwanese clinical breast cancer population: a case-control study.

Hsiao WC, Young KC, Lin SL, Lin PW.

Breast Cancer Res. 2004;6(3):R180-6. Epub 2004 Feb 26.

20.

Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women.

Pooja S, Chaudhary P, Nayak LV, Rajender S, Saini KS, Deol D, Kumar S, Bid HK, Konwar R.

Cytokine. 2012 Oct;60(1):122-8. doi: 10.1016/j.cyto.2012.06.241. Epub 2012 Jul 18.

PMID:
22818022

Supplemental Content

Support Center